Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung  by Sato, Masami et al.
Lymphatic flow in cases of cancer of the left lung some-
times results in upper mediastinal lymphadenopathy.1 Some
intensive trials2,3 of upper mediastinal node dissection com-
bined with lobectomy of the left lung have been carried out in
Japan. The prognosis of patients in these trials, however, was
poor, as evidenced by a high mortality and morbidity.
On the other hand, in a few patients, metastasis was limited
to the mediastinal nodes throughout the clinical course. We
have a long-surviving patient who underwent such dissection
4 years after lobectomy of the left upper lobe. The clinical sig-
nificance of the second operation for upper mediastinal lym-
phadenopathy after complete resection for left lung cancer is
still unknown. Thus, in this study, we collected and analyzed
the data on 10 similar cases in cooperation with the Japan
Lung Cancer Surgical Study Group.
Clinical data on 10 patients who underwent dissection after
lobectomy of the left lung were collected from 4 hospitals in
Japan. In all patients, swelling of upper mediastinal nodes was
not detected by chest computed tomography (CT). At the first
operation, lobectomy with systematic hilar and mediastinal
node dissection was performed through a posterolateral thora-
cotomy and then the patients were followed up. Lymphade-
nopathy of the upper mediastinum was detected by follow-up
CT except in 1 patient. In this patient, who had involvement
of the lower pretracheal node, an enlarged lymph node was
diagnosed by chest CT 27 days after the first operation.
Before the second operation, only 1 of the 10 patients had
received chemotherapy (cisplatin and vindesine).
At the second operation, a median sternotomy was used for
dissection of pretracheal nodes (No. 3), paratracheal nodes
(No. 2), and the highest mediastinal nodes (No. 1).
Histopathologic examinations revealed involvement of the
lymph nodes in each patient. In 6 of the 10 patients, the
involved nodes were completely resected. In the remaining 4
patients, however, the tumors were not removed because of
extranodal invasion to the trachea or phrenic nerve.
After the second operation, 3 patients received adjuvant
radiotherapy, and 1 underwent adjuvant radiotherapy com-
bined with chemotherapy (cisplatin and vindesine). Five-year
survival of all patients from the time of the first operation was
23%. Fig 1 shows survival after the first operation according
to the resectability at the second operation. Among the 4
patients in whom tumors were incompletely resected, there
were no 5-year survivors. On the other hand, 5-year survival
of the patients with complete resection was 44%. In 3 of the 6
patients with complete resection, mediastinal lymphadenopa-
thy had been detected more than 2 years after the first opera-
tion. The survival curve of these patients is shown in Fig 2
compared with that of 3 patients whose recurrence was detect-
ed within 2 years of the initial operation.
Follow-up since the first operation has revealed that recur-
rence was limited to lymphatic tissues in 4 patients. In the
other 6 patients, however, hematogenous metastasis with lym-
phatic involvement was also detected after the second opera-
tion and resulted in death from cancer.
Metastasis to the upper mediastinal lymph nodes often
occurs in patients with left lung cancer.1 Some intensive tri-
als such as systematic bilateral mediastinal dissection com-
bined with lobectomy performed through a median sternoto-
my for left lung cancer have failed to improve the prognosis
in such cases. On the other hand, in a few patients, metasta-
sis was limited to regional nodes throughout the clinical
course until death from cancer. Indeed, in 4 of our 10
patients, recurrence was observed in only the regional nodes.
This suggests that in some patients curative surgical resection
is possible. In the present study, survivors after the second
operation were those who had no detected recurrence for a
long period after the first operation. Martini and colleagues4
reported that recurrence developed within the first 2 years
after surgery in 60% of their patients who had a recurrence.
They also mentioned that the sites of first recurrence were
distant in most cases.4 Thus we speculate that most of the
patients who survive more than 2 years after the first opera-
tion without distant metastasis but with regional recurrence
belong to a highly limited subgroup with relatively weak or
no biologic potential for distant metastasis.
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Extensive dissection of upper mediastinal nodes combined
with lobectomy requires much time and effort and is highly
invasive. However, recurrence is frequent. In our present
study, no major complications were observed, and there were
no operative deaths.
The present study suggests that upper mediastinal node dis-
section through a median sternotomy might have a role in the
treatment of selected patients who have survived more than 2
years since the first operation and who do not have distant
metastasis but do have regional recurrence. Considering both
the biologic behavior of the tumor and the invasiveness of this
surgery, this approach may be an alternative treatment for
selected recurrence of left lung cancer.
This study was carried out by the work in Lung Cancer
Surgical Study Group (Chairman: Harubumi Kato) of JCOG
(Chairman: Masanori Shimoyama). The cases in this study
were collected from IDAC Hospital of Tohoku University
(Head: Shigefumi Fujimura), Niigata Cancer Center Hospital
(Teruaki Koike), Tochigi Cancer Center (Kohei Yokoi), and
Osaka General Medical Center (Hirohito Tada).
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Fig 1.  Survival curves after the first operation. There was no
significant difference (P = .46, log rank test). The 95% con-
fidence limits at 5 years in the group with complete resection
were 0 to 0.88.
Fig 2. Survival curves after upper mediastinal dissection
according to the length of time from the first operation to
recurrence in patients undergoing complete resection. There
was no significant difference between groups (P = .36, log
rank test). The 95% confidence limits at 4 years in group
labeled “more than 2 years” were 0.1 to 1.2.
